e-mail: [email protected] 0700 300 49 40 ,
Tirzepatide versus Semaglutide in Type 2 Diabetes (SURPASS-2). NEJM, 385(6), 503515
for instance, it is used in developing anticancer, antiviral, anti-TB, anti-hypertensive, and anti-hyperglycemic drugs (e.g., vildagliptin and saxagliptin) [52] (Figure 9)
That could mean it is not safe
But over the next five years, demand for that sort of thing will increase." ResMed an Australian medical device company that makes CPAP machines for sleep apnoea and is worth $56 billion saw a drop in its share price earlier this year largely due to the belief that GLP-1s would lead to fewer people suffering from sleep apnoea
For patients requiring additional glycaemic control, the dose may be increased to 2 mg once weekly after at least four weeks at the 1 mg dose